States Boost Oversight Of Rx Marketing; In Vt., Reps Must Discuss “Alternatives”

As of next year, pharmaceutical companies will face tougher restrictions on their marketing activities in Vermont and Nevada, and naturally, the climate in New England will be chillier: The Vermont bill is the more rigorous and comprehensive measure